» Articles » PMID: 30671672

Translating Cancer Genomics into Precision Medicine with Artificial Intelligence: Applications, Challenges and Future Perspectives

Overview
Journal Hum Genet
Specialty Genetics
Date 2019 Jan 24
PMID 30671672
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

In the field of cancer genomics, the broad availability of genetic information offered by next-generation sequencing technologies and rapid growth in biomedical publication has led to the advent of the big-data era. Integration of artificial intelligence (AI) approaches such as machine learning, deep learning, and natural language processing (NLP) to tackle the challenges of scalability and high dimensionality of data and to transform big data into clinically actionable knowledge is expanding and becoming the foundation of precision medicine. In this paper, we review the current status and future directions of AI application in cancer genomics within the context of workflows to integrate genomic analysis for precision cancer care. The existing solutions of AI and their limitations in cancer genetic testing and diagnostics such as variant calling and interpretation are critically analyzed. Publicly available tools or algorithms for key NLP technologies in the literature mining for evidence-based clinical recommendations are reviewed and compared. In addition, the present paper highlights the challenges to AI adoption in digital healthcare with regard to data requirements, algorithmic transparency, reproducibility, and real-world assessment, and discusses the importance of preparing patients and physicians for modern digitized healthcare. We believe that AI will remain the main driver to healthcare transformation toward precision medicine, yet the unprecedented challenges posed should be addressed to ensure safety and beneficial impact to healthcare.

Citing Articles

Realizing the promise of machine learning in precision oncology: expert perspectives on opportunities and challenges.

Nittas V, Ormond K, Vayena E, Blasimme A BMC Cancer. 2025; 25(1):276.

PMID: 39962436 PMC: 11834663. DOI: 10.1186/s12885-025-13621-2.


Unlocking precision medicine: clinical applications of integrating health records, genetics, and immunology through artificial intelligence.

Chen Y, Hsiao T, Lin C, Fann Y J Biomed Sci. 2025; 32(1):16.

PMID: 39915780 PMC: 11804102. DOI: 10.1186/s12929-024-01110-w.


Automated classification of pathological differentiation in head and neck squamous cell carcinoma using combined radiomics models from CET1WI and T2WI.

Li Y, Li W, Xiao H, Chen W, Lu J, Huang N Clin Oral Investig. 2024; 29(1):25.

PMID: 39708187 DOI: 10.1007/s00784-024-06110-6.


Clinical and Technical Validation of OncoIndx Assay-A Comprehensive Genome Profiling Assay for Pan-Cancer Investigations.

Ramesh A, Bharde A, DSouza A, Jadhav B, Prajapati S, Hariramani K Cancers (Basel). 2024; 16(19).

PMID: 39410034 PMC: 11475161. DOI: 10.3390/cancers16193415.


Identifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review.

Manuilova I, Bossenz J, Weise A, Boehm D, Strantz C, Unberath P JMIR Res Protoc. 2024; 13:e58705.

PMID: 39230952 PMC: 11411229. DOI: 10.2196/58705.


References
1.
Cohen J, Li L, Wang Y, Thoburn C, Afsari B, Danilova L . Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018; 359(6378):926-930. PMC: 6080308. DOI: 10.1126/science.aar3247. View

2.
Li B, Krishnan V, Mort M, Xin F, Kamati K, Cooper D . Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics. 2009; 25(21):2744-50. PMC: 3140805. DOI: 10.1093/bioinformatics/btp528. View

3.
Kim S, Liu H, Yeganova L, Wilbur W . Extracting drug-drug interactions from literature using a rich feature-based linear kernel approach. J Biomed Inform. 2015; 55:23-30. PMC: 4464931. DOI: 10.1016/j.jbi.2015.03.002. View

4.
Onsongo G, Baughn L, Bower M, Henzler C, Schomaker M, Silverstein K . CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing. J Mol Diagn. 2016; 18(6):872-881. DOI: 10.1016/j.jmoldx.2016.07.001. View

5.
Vaser R, Adusumalli S, Leng S, Sikic M, Ng P . SIFT missense predictions for genomes. Nat Protoc. 2015; 11(1):1-9. DOI: 10.1038/nprot.2015.123. View